A

Amal Therapeutics

22 employees

Amal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neuroscience
Therapeutics
Biopharma
Life Science

Date founded

2012

Funding rounds raised

Total raised

$33M

from 10 investors over 10 rounds

A

Amal Therapeutics raised $33M on November 12, 2018

Investors: VI Partners AG, BioMedPartners, High-Tech Gründerfonds and 3B Future Health Fund

A

Amal Therapeutics raised $9.5M on September 5, 2017

Investors: BioMedPartners, 3B Future Health Fund, VI Partners AG and High-Tech Gründerfonds

A

Amal Therapeutics raised $3.1M on March 30, 2016

Investors: VI Partners AG and High-Tech Gründerfonds

FAQ